Literature DB >> 33819443

Watt matters: Safety and efficacy of using a 140-W high-powered holmium laser for enucleation of the prostate (HoLEP).

Ali Yıldız1, Serkan Akdemir2, Hakan Anıl3, Murat Arslan1.   

Abstract

OBJECTIVE: This study aimed to assess the perioperative and the 12-month efficacy and safety of 140 W high-powered holmium laser for enucleation of the prostate (HP-HoLEP) for the treatment of benign prostatic obstruction.
MATERIAL AND METHODS: The data of 540 patients who underwent HoLEP by a single surgeon were analyzed retrospectively. Preoperative evaluation included a physical examination with a digital rectal examination, measurement of maximum urinary flow rate (Qmax), postvoid residual volume (PVR) and prostate volume by transabdominal ultrasonography, serum prostate-specific antigen (PSA), international prostate symptom score (I-PSS) and international index of erectile function-5 (IIEF-5) questionnaires, and urine analysis. Morcellation, enucleation, and operation efficiencies were calculated with the resected weight divided by morcellation, enucleation, and operative times, respectively. The patients were reassessed at 1, 3, 6, and 12 months after surgery by I-PSS, IIEF-5, Qmax, PSA, and the occurrence of complications.
RESULTS: The mean operative time was 65.2±20.9 minutes. The mean enucleation time and efficiency were 53±15.1 minutes and 1.72±0.4 g/min, respectively. The mean morcellation time and efficiency were 12.3±15.1 minutes and 7.4±3.2 g/min respectively. Clavien grade 1 complications were observed in 102 (18.9%) patients, Clavien grade 2 complications in 20 (3.7%) patients, and Clavien grade 3b complications in 23 (5.4%) patients. I-PSS, Qmax, and IIEF-5 at postoperative 1, 3, 6, and 12 months were significantly better than baseline results.
CONCLUSION: Our study demonstrated that 140 W HP-HoLEP can be performed with high enucleation efficiency, low perioperative and postoperative complication rates, and excellent functional results.

Entities:  

Year:  2021        PMID: 33819443      PMCID: PMC8018810          DOI: 10.5152/tud.2021.20558

Source DB:  PubMed          Journal:  Turk J Urol        ISSN: 2149-3235


  30 in total

1.  Holmium:YAG laser enucleation of the prostate: multimedia description from a trainee's perspective.

Authors:  Brian C Fong; Mostafa M Elhilali
Journal:  J Endourol       Date:  2004-10       Impact factor: 2.942

2.  [Transurethral enucleation of the prostate with the holmium: YAG laser system: how much power is necessary?].

Authors:  J Rassweiler; M Roder; M Schulze; R Muschter
Journal:  Urologe A       Date:  2008-04       Impact factor: 0.639

3.  Postoperative Lower Urinary Tract Storage Symptoms: Does Prostate Enucleation Differ from Prostate Vaporization for Treatment of Symptomatic Benign Prostatic Hyperplasia?

Authors:  Mohamed A Elkoushy; Ahmed M Elshal; Mostafa M Elhilali
Journal:  J Endourol       Date:  2015-06-18       Impact factor: 2.942

4.  Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries.

Authors:  Hude Quan; Bing Li; Chantal M Couris; Kiyohide Fushimi; Patrick Graham; Phil Hider; Jean-Marie Januel; Vijaya Sundararajan
Journal:  Am J Epidemiol       Date:  2011-02-17       Impact factor: 4.897

5.  The evolution of lasers in urology.

Authors:  Amir Zarrabi; Andreas J Gross
Journal:  Ther Adv Urol       Date:  2011-04

6.  Holmium laser enucleation of the prostate versus thulium laser enucleation of the prostate for the treatment of large-volume prostates > 80 ml: 18-month follow-up results.

Authors:  Junjie Zhang; Zhenyu Ou; Xiaobo Zhang; Wei He; Ruizhe Wang; Miao Mo; Lingxiao Chen; Ran Xu; Shusuan Jiang; Xiaoyan Peng; Lin Qi; Long Wang
Journal:  World J Urol       Date:  2019-09-09       Impact factor: 4.226

Review 7.  Holmium Laser Enucleation of the Prostate: Patient Selection and Outcomes.

Authors:  Joseph M Kuebker; Nicole L Miller
Journal:  Curr Urol Rep       Date:  2017-10-19       Impact factor: 3.092

Review 8.  Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement.

Authors:  Sascha A Ahyai; Peter Gilling; Steven A Kaplan; Rainer M Kuntz; Stephan Madersbacher; Francesco Montorsi; Mark J Speakman; Christian G Stief
Journal:  Eur Urol       Date:  2010-06-11       Impact factor: 20.096

9.  Change in serum prostate specific antigen concentration after holmium laser enucleation of the prostate: a marker for completeness of adenoma resection?

Authors:  William W Tinmouth; Enmar Habib; Samuel C Kim; Ramsay L Kuo; Ryan F Paterson; Colin L Terry; Mostafa Elhilali; James E Lingeman
Journal:  J Endourol       Date:  2005-06       Impact factor: 2.942

10.  Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.

Authors:  Daniel Dindo; Nicolas Demartines; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.